TY  - JOUR 
AU  - Ruiz-Sancho, A.
AU  - Núñez-Núñez, M.
AU  - Castelo Corral, Laura María
AU  - Martínez-Marcos, F.J.
AU  - Lois-Martínez, N.
AU  - Abdul-Aziz, M.H.
AU  - Vinuesa-García, D.
PY  - 2023
SN  - 1663-9812
UR  - http://hdl.handle.net/20.500.11940/21304
AB  - Suppressive antibiotic therapy (SAT) is a strategy to alleviate symptoms and/or to reduce the progression of an infection when other treatment options cannot be used. Dalbavancin, due to its prolonged half-life, enables (bi) weekly dosing. Here, we...
LA  - eng
TI  - Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
DO  - 10.3389/fphar.2023.1185602
T2  - Frontiers in Pharmacology
KW  - AS A Coruña
KW  - CHUAC
VL  - 14
ER  -